D

Dingdang Health Technology Group Ltd
HKEX:9886

Watchlist Manager
Dingdang Health Technology Group Ltd
HKEX:9886
Watchlist
Price: 0.55 HKD 5.77%
Market Cap: 726.8m HKD
Have any thoughts about
Dingdang Health Technology Group Ltd?
Write Note

Dingdang Health Technology Group Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dingdang Health Technology Group Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
D
Dingdang Health Technology Group Ltd
HKEX:9886
Cash & Cash Equivalents
ÂĄ1.2B
CAGR 3-Years
66%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Alibaba Group Holding Ltd
NYSE:BABA
Cash & Cash Equivalents
ÂĄ183B
CAGR 3-Years
-12%
CAGR 5-Years
-5%
CAGR 10-Years
8%
Pinduoduo Inc
NASDAQ:PDD
Cash & Cash Equivalents
ÂĄ65.3B
CAGR 3-Years
80%
CAGR 5-Years
33%
CAGR 10-Years
N/A
JD Health International Inc
HKEX:6618
Cash & Cash Equivalents
ÂĄ18.7B
CAGR 3-Years
-17%
CAGR 5-Years
310%
CAGR 10-Years
N/A
Meituan
HKEX:3690
Cash & Cash Equivalents
ÂĄ54.7B
CAGR 3-Years
-8%
CAGR 5-Years
40%
CAGR 10-Years
N/A
JD.Com Inc
HKEX:9618
Cash & Cash Equivalents
ÂĄ99.1B
CAGR 3-Years
4%
CAGR 5-Years
25%
CAGR 10-Years
17%
No Stocks Found

Dingdang Health Technology Group Ltd
Glance View

Market Cap
737.8m HKD
Industry
Retail

Dingdang Health Technology Group Ltd. is an investment holding company, which engages in the provision of pharmaceutical and healthcare solutions. The company is headquartered in Beijing, Beijing and currently employs 2,933 full-time employees. The company went IPO on 2022-09-14. The firm operates two segments. The Pharmaceutical and Healthcare Business segment is engaged in online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The Others segment provides marketing services, marketplace services and other services. The firm mainly conducts businesses within the domestic market.

Intrinsic Value
1.45 HKD
Undervaluation 62%
Intrinsic Value
Price
D

See Also

What is Dingdang Health Technology Group Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.2B CNY

Based on the financial report for Dec 31, 2023, Dingdang Health Technology Group Ltd's Cash & Cash Equivalents amounts to 1.2B CNY.

What is Dingdang Health Technology Group Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
91%

Over the last year, the Cash & Cash Equivalents growth was -2%. The average annual Cash & Cash Equivalents growth rates for Dingdang Health Technology Group Ltd have been 66% over the past three years , 91% over the past five years .

Back to Top